These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3298729)

  • 21. Anaerobic bacteria in cystic fibrosis: pathogens or harmless commensals?
    Jones AM
    Thorax; 2011 Jul; 66(7):558-9. PubMed ID: 21415245
    [No Abstract]   [Full Text] [Related]  

  • 22. [Physiopathology and chemotherapy of respiratory tract infections].
    Hara K; Kono S
    Nihon Naika Gakkai Zasshi; 1990 Dec; 79(12):1689-93. PubMed ID: 2079592
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the resistance of bacterial agents of respiratory tract infections].
    Roester U
    Med Welt; 1966 Sep; 39():2080-3. PubMed ID: 5920478
    [No Abstract]   [Full Text] [Related]  

  • 24. [Agents causing respiratory tract infections and their sensitivity to antibiotics and chemotherapeutic drugs].
    Schmid W
    Med Welt; 1968 Dec; 49():2709-18. PubMed ID: 5730705
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bacterial flora in nontuberculous infections of the respiratory tract (findings relevant to the year 1988)].
    Saviano G; Borrelli G; Cerbone V; Ferrera P; La Gala F; Cuccurullo S; Corsi G
    Arch Monaldi Mal Torace; 1988; 43(6):475-85. PubMed ID: 3155011
    [No Abstract]   [Full Text] [Related]  

  • 26. [Variations of microbial sensitivity in lower respiratory tract infections].
    Aguerre MM; Costa de Mello B
    Hoja Tisiol; 1971; 28(1-2):41-76. PubMed ID: 5173683
    [No Abstract]   [Full Text] [Related]  

  • 27. Community-acquired bacterial respiratory tract infections.
    Brunton S; Carmichael B; Fitzgerald M; Liu H; Varon J; Weiland D
    J Fam Pract; 2005 Mar; 54(3):255-62. PubMed ID: 15755379
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemotherapy of refractory infections--selection and application of anti-microbial agents].
    Nihon Rinsho; 1988 Jul; 46 Suppl():345-89. PubMed ID: 3271255
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.
    Watanabe A; Tokue Y; Kikuchi T; Gomi K; Aoki S; Satoh T; Fujimura S
    Int J Antimicrob Agents; 2005 Nov; 26(5):420-3. PubMed ID: 16216468
    [No Abstract]   [Full Text] [Related]  

  • 30. [Refractory respiratory tract infections. 8. Clinical efficacy and application of combined therapy with antibiotics. a. Immunoglobulin therapy].
    Katsunuma H; Kubo H; Sakurai H; Matsuishi T; Kanaya K; Arai H; Noguchi S; Ohsawa Y; Koo M; Hayashi J
    Nihon Rinsho; 1987 Mar; 45(3):588-99. PubMed ID: 3599485
    [No Abstract]   [Full Text] [Related]  

  • 31. [Secondary respiratory tract infections occurring in residual lesion of pulmonary tuberculosis. 4. Chemotherapy of secondary respiratory tract infections].
    Ooizumi K
    Kekkaku; 1986 Dec; 61(12):654-7. PubMed ID: 3573504
    [No Abstract]   [Full Text] [Related]  

  • 32. Opportunistic Pulmonary Infections in the Solid Organ Transplant Recipient: A Focus on Drug Therapy.
    Goetz ME; Evans RA; Rendulic T
    Crit Care Nurs Q; 2017; 40(4):399-413. PubMed ID: 28834861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of lower respiratory tract infections in elderly].
    Iakovlev SV
    Ter Arkh; 1997; 69(12):57-63. PubMed ID: 9503539
    [No Abstract]   [Full Text] [Related]  

  • 34. Short-duration therapy for respiratory tract infections.
    Goff DA
    Ann Pharmacother; 2004 Sep; 38(9 Suppl):S19-23. PubMed ID: 15226490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriology in respiratory tract infections.
    Percival A
    BTTA Rev; 1972 Jun; 2(2):36. PubMed ID: 5035108
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of anaerobic pulmonary infections.
    Bartlett JG
    J Antimicrob Chemother; 1989 Dec; 24(6):836-40. PubMed ID: 2695509
    [No Abstract]   [Full Text] [Related]  

  • 37. [Refractory respiratory tract infections. 6. New problems in refractory respiratory tract infections. c. Chemotherapy of methicillin-resistant Staphylococci infection].
    Konno M
    Nihon Rinsho; 1987 Mar; 45(3):565-70. PubMed ID: 3298734
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel agents for the treatment of outpatient respiratory tract infections. Introduction.
    Pell DM
    Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592
    [No Abstract]   [Full Text] [Related]  

  • 39. Bactericidal effect of propolis in vitro against agents causing upper respiratory tract infections.
    Focht J; Hansen SH; Nielsen JV; van den Berg-Segers A; Riezler R
    Arzneimittelforschung; 1993 Aug; 43(8):921-3. PubMed ID: 8216454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The possibilities and limits of bacteriologic diagnosis in nontuberculous bacterial lower respiratory infections].
    Stoicescu IP; Strâmbu I
    Pneumologia; 2000; 49(2):141-5. PubMed ID: 11016261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.